Enterococcal Peritonitis in Peritoneal Dialysis Patients: Last Name Matters

Arias C.A. , Murray B.E. Enterococcus species, streptococcus bovis group and leuconostoc species. In: Mandell G.L. , Bennett J.E. , Dolin R. , eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Churchill-Livingstone–Elsevier; 2010: 2643–53.

Fisher K. , Phillips C. The ecology, epidemiology and virulence of Enterococcus. microbiology 2009; 155: 1749–57.

Brandl K. , Plitas G. , Mihu C.N. , Ubeda C. , Jia T. , Fleisher M. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455: 804–7.

Mutnick A.H. , Biedenbach D.J. , Jones R.N. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2003; 46: 63–8.

Goodman E.R. , Platt R. , Bass R. , Onderdonk A.B. , Yokoe D.S. , Huang S.S. Impact of an environmental cleaning intervention on the presence of methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008; 29: 593–9.

Foulquié Moreno M.R. , Sarantinopoulos P. , Tsakalidou E. , De Vuyst L. The role and application of enterococci in food and health. Int J Food Microbiol 2006; 106: 1–24.

Gorbach S.L. Intraabdominal infections. Clin Infect Dis 1993; 17: 961–5.

Burnett R.J. , Haverstock D.C. , Dellinger E.P. , Reinhart H.H. , Bohnen J.M. , Rotstein O.D. Definition of the role of Enterococcus in intraabdominal infection: analysis of a prospective randomized trial. surgery 1995; 118: 716–21.

Ono S. , Muratani T. , Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Anti-microb Agents Chemother 2005; 49: 2954–8.

Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710–21.

Klare I. , Konstabel C. , Badstübner D. , Werner G. , Witte W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003; 88: 269–90.

Arias C.A. , Contreras G.A. , Murray B.E. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 2010; 16: 555–62.

Pérez Fontan M. , Rodríguez–Carmona A. , García–Naveiro R. , Rosales M. , Villaverde P. , Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274–84.

Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; (103): S55–62.

Sutherland S.M. , Alexander S.R. , Feneberg R. , Schaefer F. , Warady BA on behalf of the International Pediatric Peritonitis Registry (IPPR). Enterococcal peritonitis in children receiving peritoneal dialysis. Nephrol Dial transplant 2010; 25: 4048–54.

Edey M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 patients. Nephrol Dial transplant 2010; 25: 1272–8.

Barraclough K. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment and outcomes. Am J Kidney Dis 2010; 55: 121–31.

Pérez–Fontán M. , Rodríguez–Carmona A. , Rosales M. , García–Falcón T. , Valdés F. Incidence and clinical significance of nasal and pericatheter colonization by gram-negative bacteria among patients undergoing chronic peritoneal dialysis. Nephrol Dial transplant 2002; 17: 118–22.

Szeto C.C. , Kwan B.C. , Chow K.M. , Law M.C. , Pang W.F. , Chung K.Y. Recurrent and relapsing peritonitis: causative organisms and response to treatment. Am J Kidney Dis 2009; 54: 702–10.

Yip T. , Tse K.C. , Ng F. , Hung I. , Lam M.F. , Tang S. Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients. Perit Dial Int 2011; 31: 522–528.

Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. Peritoneal dialysis–related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423.

Troidle L. , Kliger A.S. , Gorban–Brennan N. , Fikrig M. , Golden M. , Finkelstein F.O. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 1996; 50: 1368–72.

Lynn W.A. , Clutterbuck E. , Want S. , Markides V. , Lacey S. , Rogers T.R. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 1994; 344: 1025–6.

Bailey E.M. , Faber M.D. , Nafziger D.A. Linezolid for treatment of vancomycin resistant enterococcal peritonitis. Am J Kidney Dis 2001; 38: E20.

DePestel D.D. , Peloquin C.A. , Carver P.L. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis. Pharmacotherapy 2003; 23: 1322–6.

Tedla F.M. , Salifu M. , Friedman E.A. Successful treatment of vancomycin-resistant enterococcal peritonitis with linezolid in a kidney transplant patient: a case report and review of the literature. Perit Dial Int 2004; 24: 70–2.

Hassoun A.A. , Coomer R.W. , Mendez–Vigo L. Intraperitoneal daptomycin used to successfully treat vancomycin-resistant Enterococcus peritonitis. Perit Dial Int 2009; 29: 671–3.

Huen S.C. , Hall I. , Topal J. , Mahnensmith R.L. , Brewster U.C. , Abu-Alfa A.K. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant Enterococcus peritonitis. Am J Kidney Dis 2009; 54: 538–41.